Literature DB >> 11368521

Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.

J Marcinkeviciene1, W Jiang, L M Kopcho, G Locke, Y Luo, R A Copeland.   

Abstract

Steady-state kinetics, equilibrium binding, and primary substrate kinetic isotope effect studies revealed that the reduction of crotonyl-CoA by NADH, catalyzed by Haemophilus influenzae enoyl-ACP reductase (FabI), follows a rapid equilibrium random kinetic mechanism with negative interaction among the substrates. Two biphenyl inhibitors, triclosan and hexachlorophene, were studied in the context of the kinetic mechanism. IC(50) values for triclosan in the presence and absence of NAD(+) were 0.1 +/- 0.02 and 2.4 +/- 0.02 microM, respectively, confirming previous observations that the E-NAD(+) complex binds triclosan more tightly than the free enzyme. Preincubation of the enzyme with triclosan and NADH suggested that the E-NADH complex is the active triclosan binding species as well. These results were reinforced by measurement of binding kinetic transients. Intrinsic protein fluorescence changes induced by binding of 20 microM triclosan to E, E-NADH, E-NAD(+), and E-crotonyl-CoA occur at rates of 0.0124 +/- 0.001, 0.0663 +/- 0.002, 0.412 +/- 0.01, and 0.0069 +/- 0.0001 s(-1), respectively. The rate of binding decreased with increasing crotonyl-CoA concentrations in the E-crotonyl-CoA complex, and the extrapolated rate at zero concentration of crotonyl-CoA corresponded to the rate observed for the binding to the free enzyme. This suggests that triclosan and the acyl substrate share a common binding site. Hexachlorophene inhibition, on the other hand, was NAD(+)- and time-independent; and the calculated IC(50) value was 2.5 +/- 0.4 microM. Steady-state inhibition patterns did not allow the mode of inhibition to be unambiguously determined, but binding kinetics suggested that free enzyme, E-NAD(+), and E-crotonyl-CoA have similar affinity for hexachlorophene, since the k(obs)s were in the same range of 20-24 s(-1). When the E-NADH complex was mixed with hexachlorophene ligand, concentration-independent fluorescence quenching at 480 nm was observed, suggesting at least partial competition between NADH and hexachlorophene for the same binding site. Mutual exclusivity studies, together with the above-discussed results, indicate that triclosan and hexachlorophene bind at different sites of H. influenzae FabI. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368521     DOI: 10.1006/abbi.2001.2349

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.

Authors:  Kirk E Hevener; Shahila Mehboob; Teuta Boci; Kent Truong; Bernard D Santarsiero; Michael E Johnson
Journal:  Protein Expr Purif       Date:  2012-07-20       Impact factor: 1.650

Review 2.  Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition.

Authors:  Fernanda S M Hopf; Candida D Roth; Eduardo V de Souza; Luiza Galina; Alexia M Czeczot; Pablo Machado; Luiz A Basso; Cristiano V Bizarro
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

3.  Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.

Authors:  Hao Lu; Peter J Tonge
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

4.  Investigation of fatty acid elongation and desaturation steps in Fusarium lateritium by quantitative two-dimensional deuterium NMR spectroscopy in chiral oriented media.

Authors:  Vincent Baillif; Richard J Robins; Steven Le Feunteun; Philippe Lesot; Isabelle Billault
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

5.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

6.  Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene.

Authors:  Oren Zimhony; Catherine Vilchèze; William R Jacobs
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

7.  Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus.

Authors:  Hua Xu; Todd J Sullivan; Jun-ichiro Sekiguchi; Teruo Kirikae; Iwao Ojima; Christopher F Stratton; Weimin Mao; Fernando L Rock; M R K Alley; Francis Johnson; Stephen G Walker; Peter J Tonge
Journal:  Biochemistry       Date:  2008-03-13       Impact factor: 3.162

8.  Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.

Authors:  Mili Kapoor; P L Swarna Mukhi; Namita Surolia; K Suguna; Avadhesha Surolia
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

9.  Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.

Authors:  Andrew Chang; Johannes Schiebel; Weixuan Yu; Gopal R Bommineni; Pan Pan; Michael V Baxter; Avinash Khanna; Christoph A Sotriffer; Caroline Kisker; Peter J Tonge
Journal:  Biochemistry       Date:  2013-06-06       Impact factor: 3.162

Review 10.  Triclosan: An Update on Biochemical and Molecular Mechanisms.

Authors:  Mohammad A Alfhili; Myon-Hee Lee
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.